Anibal Drelichman

945 total citations
25 papers, 730 citations indexed

About

Anibal Drelichman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Anibal Drelichman has authored 25 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 6 papers in Otorhinolaryngology. Recurrent topics in Anibal Drelichman's work include Head and Neck Cancer Studies (6 papers), Prostate Cancer Treatment and Research (4 papers) and Cancer Diagnosis and Treatment (3 papers). Anibal Drelichman is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Prostate Cancer Treatment and Research (4 papers) and Cancer Diagnosis and Treatment (3 papers). Anibal Drelichman collaborates with scholars based in United States and Netherlands. Anibal Drelichman's co-authors include Muhyi Al‐Sarraf, Joseph B. Jacobs, David A. Decker, Arthur Weaver, Melvin L. Reed, Judith A. Hoschner, Julie A. Kish, John D. Crissman, Glenn Cummings and Vainutis K. Vaitkevicius and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Urology.

In The Last Decade

Anibal Drelichman

25 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anibal Drelichman United States 12 382 337 261 235 113 25 730
Fred Rosen United States 13 669 1.8× 846 2.5× 570 2.2× 556 2.4× 241 2.1× 22 1.3k
Vishram B. Rege United States 14 484 1.3× 63 0.2× 449 1.7× 105 0.4× 98 0.9× 19 827
E. Sandberg Denmark 10 382 1.0× 90 0.3× 163 0.6× 221 0.9× 60 0.5× 17 749
Josef Kovařík United Kingdom 10 169 0.4× 102 0.3× 139 0.5× 98 0.4× 62 0.5× 42 449
E. del Barco Spain 17 341 0.9× 149 0.4× 260 1.0× 95 0.4× 145 1.3× 66 629
D. Turci Italy 14 492 1.3× 56 0.2× 250 1.0× 109 0.5× 74 0.7× 43 637
G.P.M. ten Velde Netherlands 15 452 1.2× 52 0.2× 619 2.4× 100 0.4× 144 1.3× 31 921
W. J. Stuckey United States 15 239 0.6× 45 0.1× 380 1.5× 327 1.4× 163 1.4× 32 771
Robert A. Rostock United States 14 256 0.7× 40 0.1× 193 0.7× 270 1.1× 83 0.7× 26 695
Günther Klautke Germany 19 605 1.6× 77 0.2× 467 1.8× 456 1.9× 85 0.8× 69 1.0k

Countries citing papers authored by Anibal Drelichman

Since Specialization
Citations

This map shows the geographic impact of Anibal Drelichman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anibal Drelichman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anibal Drelichman more than expected).

Fields of papers citing papers by Anibal Drelichman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anibal Drelichman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anibal Drelichman. The network helps show where Anibal Drelichman may publish in the future.

Co-authorship network of co-authors of Anibal Drelichman

This figure shows the co-authorship network connecting the top 25 collaborators of Anibal Drelichman. A scholar is included among the top collaborators of Anibal Drelichman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anibal Drelichman. Anibal Drelichman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anthony, Lowell, Nashat Gabrail, Hassan Ghazal, et al.. (2011). IV iron sucrose for cancer and/or chemotherapy-induced anemia in patients treated with erythropoiesis-stimulating agents. Community Oncology. 8(6). 270–278. 11 indexed citations
2.
Beer, Tomasz M., Bryan Goldman, Timothy W. Synold, et al.. (2008). Southwest Oncology Group Phase II Study of Ispinesib in Androgen-Independent Prostate Cancer Previously Treated with Taxanes. Clinical Genitourinary Cancer. 6(2). 103–109. 48 indexed citations
3.
Bellet, Robert E., Hassan Ghazal, Marshall S. Flam, et al.. (2007). A phase III randomized controlled study comparing iron sucrose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing chemotherapy and erythropoietin stimulating agent (ESA) therapy. Journal of Clinical Oncology. 25(18_suppl). 9109–9109. 16 indexed citations
4.
John, Timothy G., et al.. (2006). Leiomyosarcoma of scrotum—case report and review of literature. Urology. 67(2). 424.e13–424.e15. 25 indexed citations
5.
Lobocki, Catherine, et al.. (2006). Use of statins and breast carcinoma: A case-control study. Journal of Clinical Oncology. 24(18_suppl). 592–592. 3 indexed citations
6.
Drelichman, Anibal, et al.. (2006). Quality Performance Improvement With the Implementation of Standard Chemotherapy Order Forms. Journal of Oncology Practice. 2(3). 104–107. 6 indexed citations
7.
Lobocki, Catherine, et al.. (1997). Bromodeoxyuridine improves the cytotoxic effect of cisplatin: a comparison with 5-fluorouracil. Cancer Chemotherapy and Pharmacology. 40(6). 463–468. 8 indexed citations
8.
Drelichman, Anibal, et al.. (1985). Evaluation of cyclophosphamide, adriamycin, and cis-platinum (CAP) in patients with disseminated prostatic carcinoma. American Journal of Clinical Oncology. 8(3). 255–259. 9 indexed citations
9.
10.
Drelichman, Anibal, David A. Decker, Muhyi Al‐Sarraf, Vainutis K. Vaitkevicius, & Jaroslaw Muz. (1984). Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma. Cancer. 53(5). 1061–1065. 10 indexed citations
11.
12.
Decker, David A., Anibal Drelichman, Muhyi Al‐Sarraf, John D. Crissman, & Melvin L. Reed. (1983). Chemotherapy for nasopharyngeal carcinoma a ten-year experience. Cancer. 52(4). 602–605. 94 indexed citations
13.
Drelichman, Anibal, et al.. (1983). Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer.. PubMed. 67(12). 1133–5. 24 indexed citations
14.
15.
Drelichman, Anibal, et al.. (1982). M-AMSA in disseminated prostatic carcinoma: a phase II study.. PubMed. 66(11). 1993–4. 6 indexed citations
16.
Kish, Julie A., Anibal Drelichman, Joseph B. Jacobs, et al.. (1982). Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.. PubMed. 66(3). 471–4. 179 indexed citations
17.
Weaver, Arthur, Susan M. Fleming, Henry J. Vandenberg, et al.. (1982). cis‐Platinum and 5‐fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck. Head & Neck Surgery. 4(5). 370–373. 14 indexed citations
18.
Ratanatharathorn, V., et al.. (1982). Phase II evaluation of 4ʼ-(9-acridinylamino)-methanesulfon-m-anisidine (AMSA) in patients with advanced head and neck cancers. American Journal of Clinical Oncology. 5(1). 29–32. 7 indexed citations
19.
Drelichman, Anibal, Robert Brownlee, & Muhyi Al‐Sarraf. (1981). Phase II study of hexamethylmelamine for disseminated prostatic carcinoma.. PubMed. 4(3). 309–12. 4 indexed citations
20.
Feun, Lynn G., Anibal Drelichman, Amnuay Singhakowinta, & Vainutis K. Vaitkevicius. (1979). Ureteral obstruction secondary to metastatic breast carcinoma. Cancer. 44(3). 1164–1171. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fred Rosen Breakdown of academic impact, for papers by Vishram B. Rege Breakdown of academic impact, for papers by E. Sandberg Breakdown of academic impact, for papers by Josef Kovařík Breakdown of academic impact, for papers by E. del Barco Breakdown of academic impact, for papers by D. Turci Breakdown of academic impact, for papers by G.P.M. ten Velde Breakdown of academic impact, for papers by W. J. Stuckey Breakdown of academic impact, for papers by Robert A. Rostock Breakdown of academic impact, for papers by Günther Klautke
Rankless by CCL
2026